Thadepalli H, White D W, Bach V T
Chemotherapy. 1981;27(4):252-8. doi: 10.1159/000237988.
In vitro efficacy of cefuroxime was tested against 333 clinical isolates of anaerobic bacteria, including 80 strains of Bacteroides fragilis. Its activity was compared with that of cefamandole and cefoxitin. In addition, the antimicrobial synergism of cefuroxime was tested in combination with either penicillin or carbenicillin against B. fragilis. At 16 microgram/ml, cefuroxime inhibited 70% of all anaerobic bacteria, but it was ineffective against 64% of B. fragilis strains tested. Cefuroxime in combination with penicillin or carbenicillin exerted excellent synergistic activity against two of the three isolates of B. fragilis tested and had an additive effect on the other. Although cefuroxime by itself is ineffective against B. fragilis, it acts synergistically with penicillin or carbenicillin.
对333株厌氧菌临床分离株(包括80株脆弱拟杆菌)进行了头孢呋辛的体外药效测试。将其活性与头孢孟多和头孢西丁进行了比较。此外,还测试了头孢呋辛与青霉素或羧苄青霉素联合使用对脆弱拟杆菌的抗菌协同作用。在16微克/毫升时,头孢呋辛抑制了70%的所有厌氧菌,但对64%的受试脆弱拟杆菌菌株无效。头孢呋辛与青霉素或羧苄青霉素联合使用,对测试的三株脆弱拟杆菌中的两株具有优异的协同活性,对另一株具有相加作用。虽然头孢呋辛单独对脆弱拟杆菌无效,但它与青霉素或羧苄青霉素具有协同作用。